Varia US Properties, a Swiss-based real estate company investing exclusively in US multifamily housing with a focus on secondary and tertiary markets, has successful issued a CHF 50 million fixed-rate bond with a coupon of 2.875% and
Tags :Yves Mauchle
Baker McKenzie advised Basilea Pharmaceutica on all legal aspects of the this PIPE transaction. The team consisted of Matthias Courvoisier (Partner, Capital Markets - pictured left), Philip Spoerlé (Senior Associate, Capital Markets - pictured right),
Baker McKenzie acted as transaction counsel. The team was led by Matthias Courvoisier (pictured left), Alexander Wyss (pictured centred) and Yves Mauchle (pictured right)
The Baker McKenzie team who advised Ultima Capital included Alexander Wyss (Partner, Transactions/Real Estate), Petra Hanselmann (Partner, Transactions/M&A)
the Swiss team consisted mainly of Matthias Courvoisier (pictured left), Yves Mauchle (pictured right) and Beau Visser
Baker McKenzie's Zurich team consisted of Lukas Glanzmann (pictured right), Marcel Giger (pictured centred) and Yves Mauchle (pictured left).
Baker McKenzie's team consisted of Matthias Courvoisier (pictured left), Yves Mauchle (pictured centred) and Beau Visser (pictured right).
Santhera Pharmaceuticals Holding announced the closing of the first tranche of its financing arrangement with a fund managed by Highbridge Capital Management. The team was led by partner Matthias Courvoisier (Capital Markets) and senior associate
The team consisted of partner Matthias Courvoisier, senior associate Yves Mauchle and trainee Jan Lusti
Zur Rose Group via its subsidiary Zur Rose Finance successfully completed the placement of senior unsecured bonds due 2025 guaranteed by the Company and convertible into registered shares of the Company.
